Baird Financial Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-118,865
Closed -$10.8M 1592
2019
Q3
$10.8M Sell
118,865
-7,189
-6% -$683K 0.04% 341
2019
Q2
$11.7M Sell
126,054
-2,674
-2% -$254K 0.05% 335
2019
Q1
$12.1M Sell
128,728
-111,611
-46% -$9.76M 0.07% 283
2018
Q4
$15.4M Sell
240,339
-139,200
-37% -$10.3M 0.1% 236
2018
Q3
$34.1M Buy
379,539
+29,037
+8% +$2.57M 0.21% 136
2018
Q2
$27.8M Sell
350,502
-8,058
-2% -$669K 0.19% 153
2018
Q1
$32M Buy
358,560
+40,496
+13% +$3.89M 0.23% 132
2017
Q4
$33.2M Sell
318,064
-103,120
-24% -$11.6M 0.24% 126
2017
Q3
$61.4M Buy
421,184
+5,503
+1% +$750K 0.46% 43
2017
Q2
$54M Buy
415,681
+19,997
+5% +$2.45M 0.42% 49
2017
Q1
$49.2M Buy
395,684
+11,923
+3% +$1.43M 0.4% 52
2016
Q4
$44.4M Buy
383,761
+20,461
+6% +$2.28M 0.39% 62
2016
Q3
$38M Buy
363,300
+12,051
+3% +$1.3M 0.34% 80
2016
Q2
$34.7M Buy
351,249
+60,065
+21% +$6.21M 0.32% 86
2016
Q1
$29.1M Buy
291,184
+53,951
+23% +$5.56M 0.28% 105
2015
Q4
$28.4M Sell
237,233
-12,281
-5% -$1.42M 0.28% 102
2015
Q3
$27M Sell
249,514
-19,025
-7% -$2.36M 0.29% 102
2015
Q2
$31.1M Buy
+268,539
New +$30.7M 0.31% 103

Other funds holding CELG

Baird Financial Group's CELG Position: Q4 2019 in Review

Baird Financial Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 118,865 shares — an estimated $10.8M sold.

Baird Financial Group first reported a position in CELG in Q2 2015 and held it in 18 quarters. The position peaked at $61.4M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Baird Financial Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Baird Financial Group sold 118,865 Celgene Corp shares in Q4 2019, an estimated $10.8M.
  • Baird Financial Group first reported a position in Celgene Corp in Q2 2015 and held it in 18 quarters.
  • Baird Financial Group's Celgene Corp position peaked at $61.4M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Baird Financial Group's 13F filing for Q4 2019, filed 14 Feb 2020.